因果规则组合方法用于估计异质治疗效果,同时考虑预后效应
Mayu Hiraishi1,2, Ke Wan3, Kensuke Tanioka4
1Clinical Study Support Center, Wakayama Medical University Hospital, Wakayama, Japan.
Statistical methods in medical research
|April 27, 2024
概括
我们开发了一个新的基于RuleFit的框架来估计临床试验中的异质治疗效应. 该方法为个性化治疗策略提供了可解释的规则,其表现与其他组合方法相当.
科学领域:
- 生物统计学 生物统计学
- 机器学习 机器学习
- 临床试验方法论 临床试验方法论
背景情况:
- 估计异质治疗效应 (HTE) 对个性化医学至关重要.
- 现有的方法可能缺乏解释性或需要复杂的建模.
- 随机临床试验 (RCT) 为评估治疗疗效提供了一个强大的框架.
研究的目的:
- 提出一种新的,可解释的框架,用于在RCT中估计HTE.
- 利用RuleFit方法来确定预后和规范性规则.
- 证明拟议方法的实际应用和性能.
主要方法:
- 开发了一个使用RuleFit算法的框架来构建一个规则集.
- 整体包括预测规则,规范规则和预测器的线性效应.
- 在规则中加入了一个预测术语,以隔离HTE组件.
主要成果:
- 数字模拟证实,拟议方法的性能相当于现有的集体学习技术.
- 从模型中获得的规范性规则提供了HTE的可解释描述.
- 应用到现实世界的数据证明了框架的可解释性和实用性.
结论:
- 拟议的基于RuleFit的框架有效地估计了具有高可解释性的RCT中的HTE.
- 这种方法有助于识别那些从特定治疗中受益最多的患者子组.
- 该方法通过临床试验分析为推进精准医学提供了有价值的工具.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
178
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
178
Kaplan-Meier Approach
133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133
The Mantel-Cox Log-Rank Test
357
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
357
Causality in Epidemiology
397
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
397
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Censoring Survival Data
87
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
87


